Table 1 Preoperative patient demographics and surgical characteristics
Patients | |
|---|---|
 Age, years | 70.0 ± 9.7 |
 Sex, male | 399 (79) |
 Smoking history | 313 (62) |
 BMI, kg/m2 | 23.7 ± 3.3 |
 NYHA functional class | 2 (1–2) |
 Hypertension | 418 (82) |
 Dyslipidemia | 403 (79) |
 Diabetes | 307 (60) |
 Stroke | 103 (60) |
 Atrial fibrillation | 43 (8) |
 Malignancy | 12 (2) |
 Hemodialysis | 50 (10) |
 Pulmonary hypertension | 0 (0) |
 Preoperative beta blocker use | 314 (62) |
 Preoperative statin use | 350 (69) |
 Hemoglobin, g/dL | 11.5 ± 1.9 |
 LVEF, % | 57.5 ± 12.7 |
 Moderate/severe MR | 15 (3) |
 Estimated GFR, mL/min/1.73 m2 | 57.7 ± 25.6 |
 Pacemaker implanted | 12 (2) |
 Scheduled IABP use | 221 (44) |
Surgery | |
 Operative time, min | 208 ± 47 |
 Intraoperative blood loss, mL | 908 (619–1266) |
 Number of anastomoses | 3.0 ± 1.0 |
 LAD + diagonal branch | 1.4 ± 0.5 |
 LCX | 0.9 ± 0.6 |
 RCA | 0.7 ± 0.6 |
 Emergency surgery | 20 (4) |